 | |
- close
- close
|
FierceBiotech
Dec 2
Comment
We've lined up two more clinical trial experts to offer you some fresh insights into more efficient trial designs for our webinar on December 15th at 2 p.m. EST. Dr. Royce Morrison, director of clinical strategy for Charles River Clinical...
PR Newswire
Dec 1
Comment
BOSTON, Dec. 1 /PRNewswire-FirstCall/ -- An expert from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will lead a panel discussion on innovative approaches to drug development in Asia at the
PR Newswire
Nov 18
Comment
BOSTON, Nov. 18 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will provide insights into evolving pharmacovigilance trends and their impact on
PR Newswire
Nov 17
Comment
BOSTON, Nov. 17 /PRNewswire-FirstCall/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has expanded its leading medical imaging
StreetInsider.com
Nov 16
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Parexel+%28PRXL%29+to+Neutral%2C+Downgrades+Kendle+%28KNDL%29+to+Sell/5111329.html for the full story.
PR Newswire
Nov 10
Comment
BOSTON, Nov. 10 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Credit Suisse 18th Annual Healthcare Conference in Phoenix, AZ. Josef von Rickenbach, Chairman and Chief Executive
PR Newswire
Nov 9
Comment
BOSTON, Nov. 9 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development
PR Newswire
Nov 5
Comment
BOSTON, Nov. 5 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, announced today that it has established The Expert Office(TM) at PAREXEL. The Expert Office, which
PR Newswire
Nov 3
Comment
BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- An expert from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address the role that clinical trials in China can play in achieving cost savings and
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
PRXL AT A GLANCE
References
| ||||||
|
|
